We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,560.00
Bid: 3,560.00
Ask: 3,565.00
Change: 10.00 (0.28%)
Spread: 5.00 (0.14%)
Open: 3,520.00
High: 3,570.00
Low: 3,520.00
Prev. Close: 3,550.00
CLDN Live PriceLast checked at -
Caledonia is an Investment Trust

To grow net assets and dividends over the long term, whilst managing risk to avoid permanent loss of capital.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Unaudited net asset value and portfolio update

6 Oct 2023 07:00

RNS Number : 8978O
Caledonia Investments PLC
06 October 2023

Caledonia Investments plc

Unaudited net asset value and portfolio update

Caledonia Investments plc ("Caledonia") announces that its unaudited diluted net asset value per share ("NAV") as at 30 September 2023, calculated on a cum-income basis, was 5203p. This incorporates the biannual revaluation of the Private Capital portfolio.

The NAV total return ("NAVTR") for the six months to 30 September 2023 was 3.7%. A final dividend of 49.2p per ordinary share for the year ended 31 March 2023 was paid to shareholders on 3 August 2023, amounting to a payment of £27m.

This announcement provides a further update on Caledonia's portfolio and should be read in conjunction with the factsheet dated 30 September 2023 and released on 6 October 2023, a copy of which is available at www.caledonia.com.

Summary

All three pools generated good, positive returns in the first half of the year. The impact of foreign exchange rate movements was limited, with Sterling weakening by 1.3% against the US dollar and strengthening by 1.3% against the Euro in the period.

The Quoted Equity pool produced a return of 2.8%, reflecting the mixed performance of global public equity markets. The Private Capital portfolio produced a return of 5.9% following the biannual revaluation of our holdings, reflecting the contractually agreed disposal of Seven Investment Management ("7IM") and that most of the investee businesses are performing well. The Funds portfolio returned 4.6% based on modest valuation growth across both our Asian and North American funds, although there has been a notable slowdown in the level of fund distributions in the period reflecting reduced market transaction activity.

Performance for the first half is summarised in the table below.

Caledonia pool performance

Net asset value - Half Year to 30 September 2023

£m

NAV

31/3/23

Net

investment

/(disposal)

Capital

gains /

(losses)

Other

NAV

30/9/23

Income

Total

Return

Quoted Equity

836.9

16.5

11.5

-

864.9

12.0

2.8%

Private Capital

824.0

156.7

44.2

2.1

1,027.0

11.6

5.9%

Funds

873.8

49.7

39.6

-

963.1

1.6

4.6%

Portfolio

2,534.7

222.9

95.3

2.1

2,855.0

25.2

Net Cash/(Debt)

221.6

(222.9)

-

(18.8)

(20.1)

Other assets

41.7

-

-

(1.4)

40.3

Net assets

2,798.0

-

95.3

(18.1)

2,875.2

NAVTR

3.7%

Caledonia has continued to invest and dispose of assets, in line with our active approach to portfolio management. The movement in net debt in the first half of the year was £243m, largely reflecting net investments made by all three pools and, most significantly, the acquisition of a majority stake in the European division of AIR-serv in April 2023 by Private Capital. The Quoted Equity pool made significant additions to its holdings in three companies, refined positions in a number of others and reduced positions in two high performing stocks, creating a net investment outflow of £17m. The Funds pool has seen an increased level of drawdowns, including the purchase of secondary positions in two Decheng funds at attractive levels of discount, and only modest fund distributions, resulting in a net cash outflow of £50m in the period.

There was a notable reduction in cash in the first half of the year to support investment activity. However, with the bulk of the company's bank facilities undrawn and the c.£255m proceeds of the 7IM disposal likely to be received in the second half of the year, the total liquidity position remains healthy. Caledonia's £250m banking facilities include £137.5m expiring in November 2027, with the balance of £112.5m expiring in July 2025.

Caledonia Quoted Equity - Capital and Income portfolios (30% of NAV)

The total return on the Quoted Equity pool was 2.8% over the first half of the year. This outcome reflected the mixed performance of major markets during the period with technology stocks being in favour and US indices moving more positively than the UK, together with muted performance in Asia.

The Capital portfolio delivered a return of 4.6%. Key stocks Hill & Smith, Charter Communications, Microsoft, Oracle and Watsco delivered very strong returns ranging from 10% to 30%, in contrast to the first half of the previous financial year. However, these gains were partially offset by notable price reductions for Croda International, Spirax Sarco, Texas Instruments and Thermo Fisher Scientific.

The Income portfolio delivered a return of -2.2% with the majority of holdings recording adverse share price movements. These adverse returns were partially offset by stronger performance from RELX, Watsco and Sabre. The performance of Sabre reflects premium growth following a difficult trading period last year.

Trading activity remained limited, in line with our long-term investment approach, with increases in our holdings in Symrise, Croda International and RELX. We sold down a portion of our holdings in Oracle and Watsco, following a period of strong share price appreciation. Other activity was restricted to refining positions in existing investments resulting in our Income portfolio moving closer to its target of £250m of invested cost.

Caledonia Private Capital (36% of NAV)

Caledonia's Private Capital portfolio is dominated by significant positions in five UK-centric businesses and one private European investment company. These six investments represent over 90% of the pool's value. Investee companies are revalued in March and September each year. The portfolio generated a total return of 5.9% in the first half of the year. The five UK centric businesses are well-established and have strong market positions. With the exception of Cooke Optics, as outlined below, all are growing, profitable and cash generative. Excluding 7IM, the remaining four businesses are valued on an earnings multiple basis, with multiples in the range 9 to 14 times current year earnings. Gearing levels are modest, with net debt of approximately 2 times earnings before interest, tax, depreciation and amortisation ("EBITDA").

In early September 2023, Caledonia announced that we had agreed terms for the sale of our majority stake in 7IM, a vertically integrated retail wealth management business, to Ontario Teachers' Pension Plan Board. The transaction is subject to change in control approval by the Financial Conduct Authority and is expected to complete in late 2023 or early 2024. Subject to the exact timing of completion, we expect to receive cash proceeds of c.£255m, net of transaction expenses, for the sale of our ordinary and preference shares in 7IM. The valuation at the end of September of £248m, reflects expected cash proceeds less a 3% discount to equity value in recognition of the very limited degree of transaction execution risk. 7IM generated a return of 28.0% in the first half of the year.

Cobepa, the Belgian based investment company, owns a diverse portfolio of private global investments. The majority of the businesses within the Cobepa portfolio continue to develop well, with many delivering strong performance and valuation progression. Two significant disposals, one of which completed in the period, have been agreed which, together with progress from portfolio companies, supported the overall modest uplift in valuation. The valuation of Caledonia's holding of Cobehold, the holding company of Cobepa, was £179m at the end September, a return of 3.1% for the first half of the year.

Stonehage Fleming, the international multi-family office, continues to deliver good earnings growth across both the Family Office and Investment Management businesses. The former has seen a positive combination of new client wins and increased activity levels with existing clients; the latter has felt the benefit of recovering equity markets. Valuation at the end of September was £157m, a return of 11.7% for the first half of the year.

AIR-serv, a leading designer and manufacturer of air, vacuum and jet wash machines, which it provides to fuel station forecourt operators across the UK and Western Europe, was acquired in April 2023. The business is trading well with earnings slightly ahead of expectations and demonstrating good year on year growth. The valuation has been maintained at the equity purchase cost of £143m, generating no return for the period. The position will be reviewed in March 2024.

Liberation Group, an inns and drinks business with a pub estate stretching from Southwest London to Bristol and the Channel Islands, has traded slightly below expectations through the spring and summer. It has been adversely impacted by the cost of living crisis reducing consumer discretionary incomes, sustained cost inflation (particularly UK energy costs) and poor UK weather affecting peak early-summer trading months. However, the integration of the Cirrus Inns business, whilst not complete, has been progressing well. The valuation at the end of September was £135m, a return of 2.3% for the first half of the year.

Cooke Optics, a leading manufacturer of cinematography lenses, has been heavily impacted by the Hollywood writers' strike which started in early May 2023 and the subsequent actors' strike. With film and TV production severely affected, Cooke has seen a subsequent fall in sales and a resulting reduction in earnings. We anticipate that these industrial disputes will be resolved, with the writers' strike appearing to have concluded recently, and product demand will return. However, the timing and nature of a recovery in financial performance is uncertain. This is reflected in our valuation at the end of September of £102m, which includes a 15% equity discount to reflect this matter. The equity return is -22.7% for the first half of the year.

Caledonia Funds (33% of NAV)

The total return on the Funds portfolio was 4.6% for the first half of the year, including a 1% favourable impact from exchange rate movements. Underlying performance reflects modest valuation growth from holdings across the pool in both North America and Asia, with local currency returns of around 4% and 1% respectively.

Caledonia's fund investments are principally in third party managed private equity funds operating in North America and in Asia. The North American based funds invest into the lower-mid market, with a focus on small to medium sized, often owner-managed, established businesses. These funds normally provide the first institutional investment into these businesses, and support their professionalisation and growth, both organically and through M&A activity. The entry pricing levels are relatively modest and there is a deep, robust market for future divestment, either via trade sales or to other, larger private equity funds. The portfolio is a combination of directly owned funds (45% of Funds NAV), with a broad range of managers generally managing funds in the range of US$250m to US$500m. The balance is in fund of funds investments (13% of Funds NAV) with HighVista Strategies (formerly Aberdeen) US private equity funds, our largest single manager exposure, over five separate funds.

In contrast, our Asian based funds invest across a wide range of sectors with a focus on businesses in the early years of significant growth, having successfully developed their business model. Whilst focused on local markets, a number, particularly those with a healthcare focus, also invest into the US. The market is less developed than in North America with divestments, in the absence of a mature buyout market, mainly through an IPO or trade sale. The portfolio is a combination of directly owned funds (24% of Funds NAV), with a broad range of managers, some sourced through our fund of funds relationships but mostly through our own knowledge and contacts in the region. The balance (18% of Funds NAV) is invested with Asia Alternatives, Axiom and Unicorn, all fund of funds providers.

During the first half of the year, £52m was invested via drawdowns, £13m was invested in the secondary purchase of two Decheng funds positions and distributions of £15m, evenly balanced between North America and Asia, were received. The level of distributions has declined compared to the last two years, reflecting more challenging market conditions. We anticipate, based on feedback from our managers, something of a recovery in distributions over the next six to eighteen months.

Company contacts

Caledonia Investments plc

+44 20 7802 8080

Mat Masters

Chief Executive Officer

Rob Memmott

Chief Financial Officer

Media contacts

Teneo

+44 20 7353 4200

Tom Murray

Robert Yates

caledonia@teneo.com

6 October 2023

Notes

Valuation approach and methodology

The valuation approach utilised for each asset portfolio is summarised below.

Caledonia Quoted Equity: all listed companies are valued based on the closing bid price on the relevant exchange as at 30 September 2023.

Caledonia Private Capital: the holdings are valued biannually, principally on a normalised EBITDA x market multiple basis (in line with the latest IPEV guidelines). This approach was applied to the majority of significant assets in the portfolio on 30 September 2023. The exceptions to this approach were our holding in Cobehold, where fair value was derived from the external valuation prepared by Cobepa, and 7IM, where the valuation is derived from the contractually agreed disposal announced in early September 2023. In the case of Liberation Group, the earnings derived valuation was supported by the underlying value of the principally freehold pub estate plus the value of the drink production and distribution business.

Caledonia Funds: the fund valuations are based on the most recent valuations provided by the fund managers, subject to cash movements from the valuation date. Valuations are received 60 to 180 days from the valuation date.

Caledonia Investments plc

Caledonia is a self-managed investment trust company. Our aim is to grow net assets and dividends paid to shareholders, whilst managing risk to avoid the permanent loss of capital. This is achieved by investing in proven, well-managed businesses that combine long-term growth characteristics with an ability to deliver increasing levels of income. We hold investments in both listed and private markets, covering a range of sectors and, particularly through the listed and fund investments, have a global reach.

For additional information on Caledonia, please visit www.caledonia.com.

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NAVBIBDGCGGDGXU
Date   Source Headline
29th Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSNotice of annual results
22nd Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:30 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSUnaudited net asset value and portfolio update
2nd Apr 20247:01 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20243:19 pmRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 202410:32 amRNSDirector Declaration
6th Mar 20242:33 pmRNSNet Asset Value(s)
20th Feb 20245:02 pmRNSDirector/PDMR Shareholding
7th Feb 20241:31 pmRNSNet Asset Value(s)
30th Jan 20243:58 pmRNSDirector/PDMR Shareholding
19th Jan 20244:30 pmRNS2023 AGM results update statement
18th Jan 202411:56 amRNSDisposal
8th Jan 20247:00 amRNSUnaudited net asset value and portfolio update
7th Dec 20232:19 pmRNSNet Asset Value(s)
29th Nov 202311:49 amRNSDirector/PDMR Shareholding
27th Nov 20234:37 pmRNSDirector/PDMR Shareholding
21st Nov 20237:00 amRNSHalf-year Report
14th Nov 20233:28 pmRNSNotice of Half-Year Results
7th Nov 20237:00 amRNSNet Asset Value(s)
6th Oct 20237:00 amRNSUnaudited net asset value and portfolio update
28th Sep 20233:28 pmRNSDirector/PDMR Shareholding
25th Sep 202310:58 amRNSDirector/PDMR Shareholding
20th Sep 20239:56 amRNSDirector/PDMR Shareholding
8th Sep 20234:34 pmRNSDirector/PDMR Shareholding
7th Sep 20231:50 pmRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSCaledonia signs agreement to sell 7IM
7th Aug 20237:00 amRNSNet Asset Value(s)
19th Jul 20235:53 pmRNSResult of AGM
7th Jul 202310:22 amRNSNet Asset Value and Portfolio Update
15th Jun 20234:01 pmRNSAnnual Financial Report
9th Jun 20235:27 pmRNSDirector/PDMR Shareholding
6th Jun 202310:44 amRNSNet Asset Value(s)
1st Jun 20233:23 pmRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSDirectorate Change
23rd May 20237:00 amRNSFinal Results
9th May 20232:16 pmRNSNet Asset Value(s)
20th Apr 20239:40 amRNSAcquisition
12th Apr 202310:42 amRNSResponse to press speculation
11th Apr 20237:00 amRNSUnaudited net asset value and portfolio update
28th Mar 20231:50 pmRNSDirectorate Change
22nd Mar 20235:04 pmRNSDirector/PDMR Shareholding
14th Mar 20235:35 pmRNSDirector/PDMR Shareholding
6th Mar 20232:18 pmRNSNet Asset Value(s)
6th Feb 202311:47 amRNSNet Asset Value(s)
9th Jan 20237:00 amRNSUnaudited net asset value and portfolio update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.